Newsroom

White & Case Advises Athyrium Capital Management on the Restructuring of RevitaLid Pharmaceutical Corp. and its Subsidiaries

White & Case advises Azurity Pharmaceuticals, Inc. on acquisition of Slayback Pharma, LLC

White & Case Advises Air Water Ventures Ltd. on Business Combination with Athena Technology Acquisition Corp. II

White & Case Advises Graf Acquisition Corp. IV on Business Combination with NkGen Biotech, Inc.

White & Case Advises Biosynex on Merger Agreement With Chembio Diagnostics, Inc.

White & Case Advises Ross Acquisition Corp II on Its Business Combination with Aprinoia Therapeutics, Inc.

White & Case Advises Famy Life Sciences on Its Acquisition by Viatris Inc.

White & Case advises Apollomics Inc. on its US$899 million business combination with Maxpro Capital Acquisition Corp.

White & Case advises LOTTE Corporation on US$160 million acquisition of pharmaceutical manufacturing facility from Bristol Myers Squibb

White & Case Advises ADVANZ PHARMA on Acquisition of Intercept Pharmaceuticals

White & Case Advises Cobepa on its Investment in Reaction Biology

White & Case Advises Dominus Capital on its Investment in Uptime Institute

White & Case Advises EV Company VIA Motors on Merger with Ideanomics

White & Case Advises CM Life Sciences on Business Combination with Sema4

White & Case Advises Soaring Eagle Acquisition Corp. on Its Business Combination with Ginkgo Bioworks

White & Case Advises CM Life Sciences II on Business Combination with SomaLogic